Durect Competitors and Similar CompaniesClear all
Durect's competitors and similar companies include Avid Bioservices and BTG.
 Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. | ||
Founding Date | Founding Date N/A | Founding Date 1981 | Founding Date 1948 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Cupertino, US HQ | Locations Tustin, US HQ | |
Employees | Employees 902% increase | Employees 21114% increase | Employees 650 |
Valuation ($) | Valuation ($) 45.3 m | Valuation ($) 649.4 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods $78k (FY, 2024) | Cost of goods $132.6m (FY, 2024) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit $2m (FY, 2024) | Gross profit $7.3m (FY, 2024) | Gross profit £510.3m (FY, 2019) |
Net income | Net income ($8.3m) (FY, 2024) | Net income ($140.8m) (FY, 2024) | Net income £88.3m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Avid Bioservices
HQ
Tustin, US
Employees
211↑ 14% increase
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View company